Eli Lilly stock has surged over 200% in the past three years, driven by blockbuster revenue from weight loss drugs like Mounjaro and Zepbound. The stock recently crossed $1,000, prompting speculation about a possible stock split to make shares more accessible to investors. Stock splits are done to lower the value of individual shares without affecting market value. Companies often split stocks to make them more affordable to smaller investors. A stock split could help Lilly attract more investors and show confidence in future growth. While Lilly has a history of stock splits, the last one was before 1998, and the stock price has risen significantly since then, making a split a possibility. The decision to split will likely depend on how the stock performs in the coming weeks. Regardless of a potential split, Eli Lilly remains a solid investment option for those seeking growth and stability in their portfolios.

Read more at Yahoo Finance: Stock Split Watch: Is Eli Lilly Next?